InsidersTradesSigma
Follow the 쿼드메디슨 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 쿼드메디슨 has recorded 19 reports. The latest transaction was filed on 15 June 2026 (Purchase). Among the most active insiders: 백승기. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
19 of 19 declarations
Quad Medicine is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.